Five top medical experts from Hadassah Hospital Ein Kerem will travel to Argentina this month in order to share their expertise with colleagues and provide insight into the treatment of COVID-19 based on their own experience, Hadassah International said in a statement on Monday.
The organization further said that the two sides were holding discussions on "a phase III study of Brilife, the Israeli COVID-19 vaccine, which was developed by the Israel Institute for Biological Research and tested primarily at Hadassah."
Follow Israel Hayom on Facebook and Twitter
"Hadassah Medical Organization's delegation to Argentina seeks to provide critical knowledge and experience to frontline medical professionals in Argentina in the global fight against the COVID-19 pandemic. The Israeli delegation's visit also provides an opportunity to broaden the lines of communication and co-operation that go beyond the challenges of COVID-19 and may result in a wide range of areas in which lifesaving procedures and research can be shared for the betterment of humankind," President of Hadassah International Robert Dorfman said.
Dalia Itzik, who is the chair of the Hadassah Medical Organization's board of directors in Israel added that "Global pandemics do not know political or geographical boundaries, they hit everywhere and anywhere with the same strength, without differentiation" and noted that "these are the times when the beauty of humankind needs to prevail, and as such Hadassah's obligation is to share its knowledge and COVID-19 expertise obtained during the past 14 months when HMO treated more patients than any other hospital in Israel."
Subscribe to Israel Hayom's daily newsletter and never miss our top stories!
